APA (7th ed.) Citation

HG, R., KH, W., PA, C., H, Z., E, R., C, G., . . . MW, L. (2019). A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. Journal for immunotherapy of cancer, 7(1), 307. https://doi.org/10.1186/s40425-019-0796-5

Chicago Style (17th ed.) Citation

HG, Rammensee, et al. "A New Synthetic Toll-like Receptor 1/2 Ligand Is an Efficient Adjuvant for Peptide Vaccination in a Human Volunteer." Journal for Immunotherapy of Cancer 7, no. 1 (2019): 307. https://doi.org/10.1186/s40425-019-0796-5.

MLA (9th ed.) Citation

HG, Rammensee, et al. "A New Synthetic Toll-like Receptor 1/2 Ligand Is an Efficient Adjuvant for Peptide Vaccination in a Human Volunteer." Journal for Immunotherapy of Cancer, vol. 7, no. 1, 2019, p. 307, https://doi.org/10.1186/s40425-019-0796-5.